President Donald Trump speaks speaks on the latest developments of the coronavirus outbreak, while flanked by White House coronavirus response coordinator Debbie Birx (L), and U.S. Surgeon General Jerome Adams (R), in the James Brady Press Briefing Room at the White House March 19, 2020. (Photo by Chip Somodevilla/Getty Images)
President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
Schools are shutting down in droves as the highly contagious omicron variant surges across the country. Denisha Merriweather, director of public relations and content marketing at the American Federation for Children, an advocacy organization for vouchers and tax credits for school choice, joined Cheddar's "Opening Bell" to discuss the impact of remote learning on children. She argued that school districts have to be more proactive about the steps they are taking to engage students, and if they are unable to form better teaching methods, parents should be able to find alternative schools.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
With the Build Back Better plan essentially out of the picture, economists are highlighting what the country might lose without the provisions designed to strengthen it. Among other things, this includes no more monthly payments for tens of millions of families, no universal Pre-K for 6 million children a year, and no billions of dollars in tax incentives for climate initiatives. Grace Segers, staff writer for The New Republic, joined Cheddar to discuss the various impacts on the economy without President Biden's spending bill.
Electric vehicle companies took a tumble Monday after Senator Joe Manchin killed Biden's 'Build Back Better' plan. Shares of Tesla, Lucid, and Rivian all fell rapidly as the plan had included significant incentives for the growing EV sector. Rich Steinberg, former executive at Nissan, BMW and Electrify America joined Cheddar's Opening Bell to discuss.
Michael Robinson, Chief Technology Strategist at Money Map Press, joins Cheddar News' Closing Bell, where he explains why small and mid-cap stocks heating up during Tuesday's session is a very good sign for a stock market that ended the day's session sharply higher.
Coming off a 2021 campaign where the prices of Bitcoin, Ether, and other cryptocurrencies reached unpreceded levels, Bitwise Asset Management CIO Matt Hougan and OpenNode Co-Founder & CTO João Almeida join Cheddar News' Crypto Craze: The Year of the Token to discuss the ways the crypto market can soar even higher in 2022.
